depression, anxiety, diabetes, asthma, chronic obstructive pulmonary disease (COPD) depressie, angst, diabetes, astma, COPD
Conditions
Interventions
The current study is a randomized control trial, with an intervention of one year and an additional one year follow up. Randomization will be at patient level. All eligible primary care patients with
2) Care as usual.
Intervention group: Disease management for depression and anxiety.
The patients in the disease management arm will receive stepped care program for depression and anxiety. After ea
Step 2: Coping with depression / anxiety course. The course takes approximately 10 weeks to complete and is given individually. Improved (PHQ-9 monitoring. Not improved --> step 3
Step 3: Extension of the course with an option for additional drug treatment.
Monitoring phase: Each three months the patients are monitored using the PHQ
Sponsors
Tilburg University
Eligibility
Inclusion criteria
Inclusion criteria: 1. Having diabetes, asthma and/or COPD in primary care; 2. Depressive symptoms or anxiety symptoms; 3. 18 years or older.
Exclusion criteria
Exclusion criteria: 1. Current treatment for depression and/or anxiety; 2. Major psychiatric problems (e.g. schizophrenia, suicidality, bipolar disorder); 3. Not being able to read or speak Dutch sufficiently; 4. Being younger than 18 years old.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Depressive symptoms (PHQ-9); 2. Anxiety symptoms (GAD-7). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life (SF-12, ADDQoL, CCQ); 2. Disease specific distress (PAID); 3. Health care costs (TiC-P, EuroQoL); 4. Self-management and life style behaviours (SDSCA, SQUASH, medication adherence); 5. Satisfaction (PEQD). | — |
Contacts
Public ContactC.H. Stoop
Provincialeweg 44
Outcome results
None listed